Showing posts with label Qsymia. Show all posts
Showing posts with label Qsymia. Show all posts

Thursday, June 13, 2013

Belviq: a New Weight Loss Pill, Hits the Market

Belviq was accredited by the Federal Drug Administration (FDA) in 2013; however the medicine was postponed since it carries the possibility of mistreatment and required a regulated ingredient classification, as per News Net 5.

Belviq

Belviq, equally passes Lorcaserin HCI, and also formally released to the market since the latest of two latest weight-loss medicines that exactly where authorized by the Drug Administration in 2012. The prescribed pill, Qsymia released to the market back on September 18, 2012.

So what is Belviq? The company site states the following:

BELVIQ is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who are obese (body mass index BMI of 30 kg/m2 or greater) or

Over-weight (BMI of 27 kg/m2 or greater) with at the least one weight-related medical problem (for example, hypertension, high cholesterol levels, or type 2 diabetes).

The website additionally reports a segment on restrictions that state the following:

The safeness and performance of BELVIQ combined with prescription, non-prescription, or natural weight-loss products is not recognized.

It is certainly not recognized if BELVIQ variations the chance of heart disease or heart stroke, or of loss of life because of heart disease or stroke.


Thursday, October 18, 2012

Belviq Vs. Qsymia Ingredients: A Quantitative Approach

The Food and Drug Administration's ( FDA ) grant of the anti-fat pills Qsymia and Belviq grants reliable cures as the several overweight persons rises to for more than one-third of the U .S . human population , as well as some 300,000 US citizens expire annually of related trouble.

What are the ingredients in Belviq?
The Major ingredient in Belviq is lorcaserin hydrochloride. It also contains Silicified microcrystalline cellulose, Hydroxypropyl Cellulose NF and Croscarmellose sodium NF.

Lorcaserin: It is a weight reduction drug which is developed by Arena Pharmaceuticals. It consists of serotonergic properties and works like an anorectic. Lorcaserin hydrochloride is a serotonin 2C receptor agonist for oral administration meant for chronic weight management. Lorcaserin hydrochloride hemihydrate is a white to off-white powder with solubility in drinking water more than 400 mg/ml. On 27 June 2012, the Food and Drug Administration (FDA) officially approved lorcaserin to be used in the treating obesity for adults.

Belviq
Belviq

Other ingredients:

Silicified microcrystalline cellulose: It looks a patented mixture of 98% microcrystalline cellulose (MCC) in addition to 2% colloidal silicon dioxide (CSD). It is listed in the Inactive Ingredients Guide (IIG) on the FDA website, as a registered ingredient in New Drug Applications (NDA).

Hydroxypropyl Cellulose NF: Hydroxypropyl Cellulose is a partially replace it with poly(hydroxypropyl) ether of cellulose. It may contain not more than 0.60 % of silica or other suitable anticaking agents.
Croscarmellose sodium NF: Croscarmellose sodium also resolves formulators' concerns over long-term useful stability, reduced performance at high pill hardness levels, and also similar problems connected with other things developed to enhance medicine dissolution.

Another ingredients are polyvinyl alcohol USP, polyethylene glycol NF, titanium dioxide USP, talc USP, FD&C Blue #2 aluminum lake and magnesium stearate NF.

What are the ingredients in Qsymia?
It has two main active contents, phentermine and topiramate.
Qsymia
Qsymia

Phentermine: It is accepted as an appetite suppressant to help reduce weight in obese patients whenever utilized short-term and mixed with exercise, diet, and behavioral modification. It is normally prescribed for individuals who are at increased health care danger due to their weight and works by helping to release certain chemicals in the mind that control appetite.

Topiramate (brand name Topamax): It is an anticonvulsant (antiepilepsy) drug. Topiramate is used to treat epilepsy in children and adults, and it was initially used as an anticonvulsant. It is also Food and Drug Administration (FDA) approved for, and also most frequently recommended for, the prevention of migraines. Physicians have used topiramate to treat bipolar disorder. This drug has been inspected for use in treating alcoholism, addiction, and weight problems particularly to reduce binge eating.